|
HY-D1052-10mg
|
MedChemexpress LLC
|
Cy7-YNE
|
|
|
|
|
HY-D1052-25mg
|
MedChemexpress LLC
|
Cy7-YNE
|
|
|
|
|
HY-D1052-5mg
|
MedChemexpress LLC
|
Cy7-YNE
|
|
|
|
|
HY-14682-10mg
|
MedChemexpress LLC
|
GSK319347A [CAS 862812-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-14682-100mg
|
MedChemexpress LLC
|
GSK319347A [CAS 862812-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-14682-25mg
|
MedChemexpress LLC
|
GSK319347A [CAS 862812-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-14682-5mg
|
MedChemexpress LLC
|
GSK319347A [CAS 862812-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-14682-50mg
|
MedChemexpress LLC
|
GSK319347A [CAS 862812-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-14682-1mL
|
MedChemexpress LLC
|
GSK319347A [CAS 862812-98-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-12567-10mg
|
MedChemexpress LLC
|
ML375 [CAS 1488362-55-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12567-5mg
|
MedChemexpress LLC
|
ML375 [CAS 1488362-55-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103181-10mg
|
MedChemexpress LLC
|
N6-Cyclopentyladenosine [CAS 41552-82-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103181-100mg
|
MedChemexpress LLC
|
N6-Cyclopentyladenosine [CAS 41552-82-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103181-5mg
|
MedChemexpress LLC
|
N6-Cyclopentyladenosine [CAS 41552-82-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103181-50mg
|
MedChemexpress LLC
|
N6-Cyclopentyladenosine [CAS 41552-82-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103181-1mL
|
MedChemexpress LLC
|
N6-Cyclopentyladenosine [CAS 41552-82-3] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-50901-10mg
|
MedChemexpress LLC
|
ONO-AE3-208 [CAS 402473-54-5]
|
|
Cancer-programmed cell death
|
|
|
HY-50901-5mg
|
MedChemexpress LLC
|
ONO-AE3-208 [CAS 402473-54-5]
|
|
Cancer-programmed cell death
|
|
|
HY-50901-50mg
|
MedChemexpress LLC
|
ONO-AE3-208 [CAS 402473-54-5]
|
|
Cancer-programmed cell death
|
|
|
HY-50901-1mL
|
MedChemexpress LLC
|
ONO-AE3-208 [CAS 402473-54-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-10mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-100mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-2mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-5mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-50mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
